LINC00461: A Long Intergenic Non-Protein-Coding RNA and Its Potential as a Drug Target

Target Name: LINC00461

NCBI ID: G645323

LINC00461

LINC00461: A Long Intergenic Non-Protein-Coding RNA and Its Potential as a Drug Target

Introduction

LINC00461 is a long non-coding RNA (lncRNA) that has been identified in various organisms, including humans. It has a length of approximately 2300 nucleotides and is localized to the intergenic region, which is between the exons of two closely linked genes. LINC00461 has been shown to play a role in various cellular processes, including cell adhesion, migration, and transcriptional regulation.

Drug Target Potential

LINC00461 has been identified as a potential drug target due to its unique structure and various biological functions. One of its key features is its ability to interact with various protein-coding genes, including transcription factors that play a critical role in regulating gene expression. This interaction between LINC00461 and these transcription factors suggest that it may be a useful target for small molecules that can modulate gene expression.

Another potential mechanism by which LINC00461 may be a drug target is its role in cell signaling pathways. LINC00461 has been shown to be involved in several signaling pathways, including the TGF-β pathway and the Wnt pathway. These signaling pathways are involved in various cellular processes, including cell growth, differentiation, and survival. Therefore, small molecules that can modulate these pathways may be useful targets for LINC00461.

Expression and Function

LINC00461 has been shown to be highly expressed in various tissues and organs, including brain, heart, and muscle. It has also been shown to play a role in several biological processes, including cell adhesion, migration, and transcriptional regulation.

One of the most significant functions of LINC00461 is its role in cell adhesion. LINC00461 has been shown to be involved in the formation of tight junctions, which are critical for maintaining tissue structure and function. Additionally, LINC00461 has been shown to play a role in the regulation of cell migration, which is essential for the development and maintenance of tissues and organs.

Another function of LINC00461 is its role in transcriptional regulation. LINC00461 has been shown to interact with various transcription factors, including nuclear factor of activating T cells (NFAT), which is a critical transcription factor that plays a role in regulating gene expression.

Molecular Model and Potential Therapeutic Strategies

The molecular model of LINC00461 suggests that it has a linear structure composed of multiple exons. It has a conserved core region that includes a putative RNA-binding domain (RBD) and a unique 5' end region that includes a splicing intron and a 3' end exon. The 3' end exon includes a potential cleavage site that could be targeted by small molecules.

Based on these findings, several potential therapeutic strategies for LINC00461 could be explored. One approach could be to use small molecules that can modulate NFAT activity to regulate gene expression and potentially target LINC00461. Another approach could be to use small molecules that can alter the structure and stability of LINC00461 to enhance its stability and/or function.

Conclusion

LINC00461 is a long non-coding RNA that has been identified in various organisms, including humans. It has a unique structure and several biological functions, including cell adhesion, migration, and transcriptional regulation. Its potential as a drug target is due to its ability to interact with various transcription factors and its involvement in several cellular processes. Based on these findings, several potential therapeutic strategies for LINC00461 could be explored, including modulation of NFAT activity and alteration of its structure and stability. Further research is needed to

Protein Name: Long Intergenic Non-protein Coding RNA 461

The "LINC00461 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00461 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets